Metastatic lobular breast cancer diagnosed from a blood film
A case of Stage IA classical Hodgkin lymphoma with FDG-avid tonsils
How to manage lung infiltrates in adults suffering from haematological malignancies outside allogeneic haematopoietic stem cell transplantation
Advances in understanding the pathogenesis of graft-versus-host disease
Advances in understanding erythropoiesis: evolving perspectives
CD45RA, a specific marker for leukaemia stem cell sub-populations in acute myeloid leukaemia
No survival benefit associated with routine surveillance imaging for Hodgkin lymphoma in first remission: a Danish-Swedish population-based observational study
Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 1b study from GELTAMO group
A phase 1, open-label, dose-escalation study of pralatrexate in combination with bortezomib in patients with relapsed/refractory multiple myeloma
The potential benefit of allogeneic over autologous transplantation in patients with very early relapsed and refractory follicular lymphoma with prior remission duration of ≤12 months
Genes encoding members of the JAK-STAT pathway or epigenetic regulators are recurrently mutated in T-cell prolymphocytic leukaemia
Short duration immunochemotherapy followed by radioimmunotherapy consolidation is effective and well tolerated in relapsed follicular lymphoma: 5-year results from a UK National Cancer Research Institute Lymphoma Group study
Bendamustine + rituximab chemoimmunotherapy and maintenance lenalidomide in relapsed, refractory chronic lymphocytic leukaemia and small lymphocytic lymphoma: A Wisconsin Oncology Network Study
Predictors of early death and survival among children, adolescents and young adults with acute myeloid leukaemia in California, 1988–2011: a population-based study
Hoxa10 null animals exhibit reduced platelet biogenesis
Heavy menstrual bleeding on rivaroxaban
Monoclonal B-cell lymphocytosis and hypogammaglobulinaemia
Long non-coding RNAs: biomarkers for acute leukaemia subtypes
Higher interleukin 21 level is predictive of relapse in immune thrombocytopenia. Is it associated with activation of the complement system?
The importance of plasma D-2HG measurement in screening for IDH mutations in acute myeloid leukaemia
Autoimmune haemolytic anaemia occurring during ibrutinib therapy for chronic lymphocytic leukaemia
Autoimmune haemolytic anaemia occurring during ibrutinib therapy for chronic lymphocytic leukaemia – response to Rider et al